Citation Tools
PDFOriginal research
Why we should not ‘just use age’ for COVID-19 vaccine prioritisation
Download to a citation manager
Download the citation for this article by clicking on one of the following citation managers:
- Cite this article as:
- Why we should not ‘just use age’ for COVID-19 vaccine prioritisation
Other content recommended for you
- Risk prediction of covid-19 related death and hospital admission in adults after covid-19 vaccination: national prospective cohort study
- ‘Learn from the lessons and don’t forget them’: identifying transferable lessons for COVID-19 from meningitis A, yellow fever and Ebola virus disease vaccination campaigns
- Effectiveness of BNT162b2 and mRNA-1273 covid-19 vaccines against symptomatic SARS-CoV-2 infection and severe covid-19 outcomes in Ontario, Canada: test negative design study
- Protocol for the economic evaluation of COVID-19 pandemic response policies
- Impact of cancer diagnoses on the outcomes of patients with COVID-19: a systematic review and meta-analysis
- Severe COVID-19 outcomes among patients with autoimmune rheumatic diseases or transplantation: a population-based matched cohort study
- Comparative effectiveness of sotrovimab and molnupiravir for prevention of severe covid-19 outcomes in patients in the community: observational cohort study with the OpenSAFELY platform
- Navigating inequities: a roadmap out of the pandemic
- Global access to COVID-19 vaccines: a scoping review of factors that may influence equitable access for low and middle-income countries
- Risk factors for severity of COVID-19: a rapid review to inform vaccine prioritisation in Canada